My Expertise
Surgical Oncology. Peritoneal cancers, liver tumours, treatment of liver and lung metastasis of colorectal cancer and hydatid disease.
Keywords
Fields of Research (FoR)
Medical Biotechnology, Chemotherapy, Cancer Cell Biology, Pharmaceutical Sciences, Surgery, Medical DevicesSEO tags
Biography
Professor David L Morris is a Clinical Academic of the St George & Sutherland Clinical School, located on the grounds of St George Hospital.
Research Interests: Surgical Oncologist, principally interested in treating metastatic cancer. Large databases of peritoneal and liver surgery Peritoneal and lung metastases. Basic cancer research lab, cell biology and drug development. Three drugs from our laboratory are under...view more
Professor David L Morris is a Clinical Academic of the St George & Sutherland Clinical School, located on the grounds of St George Hospital.
Research Interests: Surgical Oncologist, principally interested in treating metastatic cancer. Large databases of peritoneal and liver surgery Peritoneal and lung metastases. Basic cancer research lab, cell biology and drug development. Three drugs from our laboratory are under development: aminoacetonitrile pathway inhibitor, benzimidazole carbamate VEGF inhibitor and enzyme combination treatment for mucin-containing cancers. Also tumour ablation – bipolar RFA probe developer.
Broad Research Areas:
Cancer Research
Qualifications:
MB, ChB, FRCS, FRCSE, MD, PhD, FRACS
Specific Research Keywords:
Peritonectomy, cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, RF Ablation, Albendazole, Bromelain, N-acetylcysteine, MUC, Monepantel
ILP/Honours research projects available for 2016:
Peritoneal cancers, effect of targeted anti-mucin agents
Pancreatic cancer
My Grants
I have hand held many peer review grants. However founded a spin off biotec company which has drugs in phase II and in the source of our lab funds.
My Research Activities
David Morris Cancer Research Fund
My Research Supervision
Supervision keywords
Areas of supervision
Devices for tumour ablation (liver, lung, pancreas)
Peritonectomy and intraperitoneal chemotherapy
Cancer therapies including ongoing mucolytic drug development
Currently supervising
Anti-cancer drug development.
Respiratory drug development
Microbial drug resistance.